These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 4925072)

  • 1. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study on cross immunity in Shigellae following local immunisation with living non-infectious agents].
    Istrati G; Meitert T; Ciufecu C; Sulea I
    Zentralbl Bakteriol Orig; 1970; 215(1):73-6. PubMed ID: 4922615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization of differentiation of antibodies to Shigella organisms according to the immunoglobulin class in the serological diagnostics of dysentery and in study of its epidemiology.
    Hasenson LB; Gennadeva TY; Lullu AV
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):298-307. PubMed ID: 4938457
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern concepts of immunity in bacterial dysentery (a review)].
    Pokrovskiĭ VI; Litinskiĭ IuI; Godovannyĭ BA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):15-21. PubMed ID: 4613079
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum enterotoxin-neutralizing antibody in human shigellosis.
    Keusch GT; Jacewicz M
    Nat New Biol; 1973 Jan; 241(105):31-2. PubMed ID: 4572837
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The keratoconjunctivitis test].
    Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):7-27. PubMed ID: 4936246
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. I. IMMUNE PHENOMENON AND ANTIBODY FORMATION.
    LIN FC; YANG TL; YEH SH
    Chin Med J; 1964 Jul; 83():454-62. PubMed ID: 14191218
    [No Abstract]   [Full Text] [Related]  

  • 13. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 15. Serologic response of patients with shiga dysentery.
    Cáceres A; Mata LJ
    J Infect Dis; 1974 Apr; 129(4):439-43. PubMed ID: 4593873
    [No Abstract]   [Full Text] [Related]  

  • 16. Future needs and directions for Shigella vaccines.
    Wkly Epidemiol Rec; 2006 Feb; 81(6):51-8. PubMed ID: 16673461
    [No Abstract]   [Full Text] [Related]  

  • 17. The Shigella human challenge model.
    Porter CK; Thura N; Ranallo RT; Riddle MS
    Epidemiol Infect; 2013 Feb; 141(2):223-32. PubMed ID: 22906296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local immunity in the parenteral immunization of guinea pigs with a ribosomal dysentery vaccine].
    Liubinskaia MM; Rukhadze EZ; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):55-9. PubMed ID: 3901625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New directions in the study of immunity in dysentery].
    Pokrovskiĭ VI; Godovannyĭ BA; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):6-12. PubMed ID: 6346759
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. II. HISTOLOGIC FINDINGS.
    LIN FC; YANG TL; WU PF
    Chin Med J; 1964 Jul; 83():463-9. PubMed ID: 14191219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.